# Karyopharm Therapeutics Inc.: Form DEF 14A, filed Apr 14, 2025

- Company: [Karyopharm Therapeutics Inc.](/companies/kpti.md) (CIK 1503802)
- Form: DEF 14A
- Filed: 2025-04-14
- Accepted by EDGAR: Apr 14, 2025, 08:15 ET
- Period: 2025-05-28
- Accession: 0000950170-25-053511
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1503802/000095017025053511/kpti-20250414.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1503802/000095017025053511/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1503802/000095017025053511/kpti-20250414.htm

Filed Apr 14, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-053511. Last ingested by Listed: Nov 5, 2026, 11:51 ET. No prices; not investment advice.